Scolnick EM. Mechanisms of action of medicines for schizophrenia and bipolar illness: status and limitations. Biol Psychiatry. 2006;59(11):1039-45. doi:10.1016/j.biopsych.2006.02.022
Scolnick EM, Petryshen T, Sklar P. Schizophrenia: do the genetics and neurobiology of neuregulin provide a pathogenesis model? Harv Rev Psychiatry. 2006;14(2):64-77. doi:10.1080/10673220600642960
Plenge RM, Padyukov L, Remmers EF, et al. Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet. 2005;77(6):1044-60. doi:10.1086/498651
Petryshen TL, Middleton FA, Tahl AR, et al. Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia. Mol Psychiatry. 2005;10(12):1074-88, 1057. doi:10.1038/sj.mp.4001739
Trinh TT, Rioux JD. The promise and perils of interpreting genetic associations in Crohn’s disease. Gut. 2005;54(10):1354-7. doi:10.1136/gut.2005.070920
Shepard JL, Amatruda JF, Stern HM, et al. A zebrafish bmyb mutation causes genome instability and increased cancer susceptibility. Proc Natl Acad Sci U S A. 2005;102(37):13194-9. doi:10.1073/pnas.0506583102
Freedman ML, Penney KL, Stram DO, et al. A haplotype-based case-control study of BRCA1 and sporadic breast cancer risk. Cancer Res. 2005;65(16):7516-22. doi:10.1158/0008-5472.CAN-05-0132
Sawcer S, Ban M, Maranian M, et al. A high-density screen for linkage in multiple sclerosis. Am J Hum Genet. 2005;77(3):454-67. doi:10.1086/444547
Rioux JD, Abbas AK. Paths to understanding the genetic basis of autoimmune disease. Nature. 2005;435(7042):584-9. doi:10.1038/nature03723
Daly MJ, Pearce AV, Farwell L, et al. Association of DLG5 R30Q variant with inflammatory bowel disease. Eur J Hum Genet. 2005;13(7):835-9. doi:10.1038/sj.ejhg.5201403